Advertisement

Product › Details
XmAb™ technology (Xencor)
![]() |
Next higher product group | antibody technology |
![]() |
Status | 2005-01-12 production/use existent |
![]() |
Organisation | Xencor Inc. (Nasdaq: XNCR) |
Record changed: 2023-07-10 |
Advertisement

More documents for antibody technology
- [1] Yumab GmbH. (1/29/25). "Press Release: Yumab and Inscreenex Get Funding for Innovative Mammalian Display Screening". Braunschweig....
- [2] Numab Therapeutics AG. (1/9/25). "Press Release: Numab Therapeutics Announces Series C Extension to CHF 180 Million, Completing Oversubscribed CHF 50 Million Financing". Horgen....
- [3] Ipsen S.A.. (12/3/24). "Press Release: Ipsen and Biomunex Announce Exclusive Global Licensing Agreement for First-in-Class MAIT Cell Engager in Immuno-oncology". Paris....
- [4] Medigene AG. (8/8/24). "Press Release: Medigene and WuXi Biologics Enter into a Research Collaboration for Off-the-Shelf TCR-Guided T Cell Engagers". Planegg-Martinsried....
- [5] Dren Bio, Inc.. (7/24/24). "Press Release: Dren Bio Announces Strategic Collaboration with Novartis to Develop Novel Targeted Myeloid Engagers for Cancer". Foster City, CA....
- [6] MorphoSys AG. (6/6/24). "Press Release: Arkadius Pichota and Lukas Gilgen Appointed to Management Board of MorphoSys AG Replacing the Current CEO and CFO (Ad hoc)". Planegg....
- [7] Numab Therapeutics AG. (5/28/24). "Press Release: Numab Therapeutics Announces Johnson & Johnson to Acquire Its Wholly-Owned Subsidiary Yellow Jersey Therapeutics Including Rights to NM26, a Bi-Specific Antibody for the Treatment of Atopic Dermatitis". H...
- [8] Biocytogen Pharmaceuticals (Beijing) Co., Ltd.. (5/6/24). "Press Release: Biocytogen Enters into Evaluation and Potential Licensing Agreement with BioCopy for TCR-mimic Antibodies". Beijing....
- [9] Scinai Immunotherapeutics Ltd.. (2/13/24). "Press Release: Scinai Welcomes Liat Halpert as Head of Business Development and Sales". Jerusalem....
- [10] Affimed N.V.. (1/3/24). "Press Release: Affimed Announces Sale of Wholly-Owned Subsidiary AbCheck". Mannheim....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top